Author

Eleonora Maretti

post-doc, University of Modena e Reggio Emilia - Cited by 585 - tecnologia farmaceutica - nanotecnologie

Biography

Dr. Eleonora Marettiis currently working as a Professor in the Department of Life Sciences, the University of Modena, and Reggio Emilia, via Campi 103, Modena, Italy. Dr. Eleonora Marettiarea of research interests includes Life Sciences.
Title
Cited by
Year
Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy
E Maretti, L Costantino, C Rustichelli, E Leo, MA Croce, F Buttini, E Truzzi, ...International journal of pharmaceutics 8 (1-2), 440-451, 2017201
52
2017
Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment⿿ A Design of Experiments approach to investigate the influence of pre-freezing conditions on …
E Maretti, C Rustichelli, M Romagnoli, AG Balducci, F Buttini, F Sacchetti, ...International Journal of Pharmaceutics 511 (1), 669-679, 2016201
41
2016
In vivo biodistribution of respirable solid lipid nanoparticles surface-decorated with a mannose-based surfactant: a promising tool for pulmonary tuberculosis treatment?
E Truzzi, TL Nascimento, V Iannuccelli, L Costantino, EM Lima, E Leo, ...Nanomaterials 10 (3), 568, 2020202
39
2020
Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy
E Maretti, L Costantino, F Buttini, C Rustichelli, E Leo, E Truzzi, ...Drug delivery and translational research 9, 298-310, 2019201
37
2019
Application of the “in-oil nanoprecipitation” method in the encapsulation of hydrophilic drugs in PLGA nanoparticles
A Dalpiaz, F Sacchetti, A Baldisserotto, B Pavan, E Maretti, V Iannuccelli, ...Journal of Drug Delivery Science and Technology 32, 283-0, 2016201
29
2016
Gastroretentive montmorillonite-tetracycline nanoclay for the treatment of Helicobacter pylori infection
V Iannuccelli, E Maretti, M Montorsi, C Rustichelli, F Sacchetti, E LeoInternational Journal of Pharmaceutics 493 (1-2), 295-304, 2015201
25
2015
Self-assembled lipid nanoparticles for oral delivery of heparin-coated iron oxide nanoparticles for theranostic purposes
E Truzzi, C Bongio, F Sacchetti, E Maretti, M Montanari, V Iannuccelli, ...Molecules 22 (6), 963, 2017201
25
2017
Enhanced anti-hyperproliferative activity of human thymidylate synthase inhibitor peptide by solid lipid nanoparticle delivery
F Sacchetti, C Marraccini, D D’Arca, M Pelà, D Pinetti, E Maretti, ...Colloids and Surfaces B: Biointerfaces 136, 346-354, 2015201
21
2015
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery
A Dalpiaz, M Fogagnolo, L Ferraro, S Beggiato, M Hanuskova, E Maretti, ...European Journal of Pharmaceutics and Biopharmaceutics 144, 91-100, 2019201
18
2019
The impact of lipid corona on rifampicin intramacrophagic transport using inhaled solid lipid nanoparticles surface-decorated with a mannosylated surfactant
E Maretti, C Rustichelli, M Lassinantti Gualtieri, L Costantino, C Siligardi, ...Pharmaceutics 11 (10), 508, 2019201
18
2019
Organo-modified bentonite for gentamicin topical application: Interlayer structure and in vivo skin permeation
V Iannuccelli, E Maretti, A Bellini, D Malferrari, G Ori, M Montorsi, M Bondi, ...Applied Clay Science 158, 158-8, 2018201
16
2018
Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation
E Truzzi, F Meneghetti, M Mori, L Costantino, V Iannuccelli, E Maretti, ...Journal of colloid and interface science 541, 399-406, 2019201
15
2019
Nasal biocompatible powder of Geraniol oil complexed with cyclodextrins for neurodegenerative diseases: Physicochemical characterization and in vivo evidences of nose to brain …
E Truzzi, C Rustichelli, ER de Oliveira Junior, L Ferraro, E Maretti, ...Journal of Controlled Release 335, 191-202, 2021202
15
2021
Chitosan/heparin polyelectrolyte complexes as ion-paring approach to encapsulate heparin in orally administrable SLN: In vitro evaluation
E Maretti, B Pavan, C Rustichelli, M Montanari, A Dalpiaz, V Iannuccelli, ...Colloids and Surfaces A: Physicochemical and Engineering Aspects 608, 125606, 2021202
14
2021
pH-promoted release of a novel anti-tumour peptide by “stealth” liposomes: Effect of nanocarriers on the drug activity in cis-platinum resistant cancer cells
F Sacchetti, G Marverti, D D’Arca, L Severi, E Maretti, V Iannuccelli, ...Pharmaceutical research 35, 1-13, 2018201
12
2018
In vivo β-carotene skin permeation modulated by Nanostructured Lipid Carriers
E Maretti, E Leo, C Rustichelli, E Truzzi, C Siligardi, V IannuccelliInternational Journal of Pharmaceutics 597, 120322, 2021202
10
2021
Characterization of natural clays from italian deposits with focus on elemental composition and exchange estimated by EDX analysis: Potential pharmaceutical and cosmetic uses
V Iannuccelli, E Maretti, F Sacchetti, M Romagnoli, A Bellini, E Truzzi, ...Clays and Clay Minerals 64 (6), 71-731, 2016201
9
2016
Inhaled micro-or nanoparticles: which are the best for intramacrophagic anti-infectious therapies?
V Iannuccelli, E MarettiJOURNAL OF INFECTIOUS DISEASES AND DIAGNOSIS 1 (1), 1-2, 2016201
7
2016
A peptidic thymidylate-synthase inhibitor loaded on pegylated liposomes enhances the antitumour effect of chemotherapy drugs in human ovarian cancer cells
G Marverti, G Gozzi, E Maretti, A Lauriola, L Severi, F Sacchetti, L Losi, ...International Journal of Molecular Sciences 21 (12), 442, 2020202
5
2020
Self-assembled organogelators as artificial stratum corneum models: Key-role parameters for skin permeation prediction
E Maretti, C Rustichelli, P Miselli, E Leo, E Truzzi, V IannuccelliInternational Journal of Pharmaceutics 557, 31-328, 2019201
4
2019

Referred From: https://scholar.google.it/citations?user=68art3wAAAAJ&hl=it

Cited by
Citations 585
h-index 15
i10-index 20
Open Access Journals